Quick Heal Technologies Limited has announced that its board of directors will convene on January 29, 2026, to deliberate on the company's quarterly financial performance. The meeting has been scheduled in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, demonstrating the company's commitment to regulatory compliance and transparent financial reporting.

Board Meeting Agenda

The primary focus of the upcoming board meeting will be the consideration and approval of the company's unaudited financial results for the third quarter of fiscal year 2026. The comprehensive review will encompass both standalone and consolidated financial statements, providing stakeholders with a complete picture of the company's financial performance during the quarter ended December 31, 2025.

Trading Window Restrictions

In adherence to the company's Code of Conduct for Prevention of Insider Trading, Quick Heal Technologies has implemented a trading window closure period. This restriction commenced on January 01, 2026, and will remain in effect until 48 hours after the financial results are publicly disclosed on January 29, 2026. The trading window closure is a standard regulatory measure designed to prevent insider trading and ensure fair market practices during sensitive periods when material information is being processed.

Regulatory Compliance

The formal intimation was communicated to both major stock exchanges where the company's shares are listed. The notification was sent to BSE Limited, where Quick Heal Technologies trades under the security code 539678 with the security ID QUICKHEAL, and to the National Stock Exchange of India Limited, where it is listed under the symbol QUICKHEAL in the EQ series.

The announcement was signed by Vikram Dhanani, serving as the Compliance Officer for Quick Heal Technologies Limited, on January 22, 2026. This formal communication ensures that all stakeholders, including investors, analysts, and regulatory bodies, are adequately informed about the scheduled board meeting and associated trading restrictions.

Quick Heal Technologies Limited has received a formal request for reclassification from a member of its Promoter Group to Public category under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The request was submitted on January 22, 2026, by Gagan Bharari Enterprises LLP.

Reclassification Request Details

The company informed stock exchanges BSE and NSE about the receipt of the reclassification request through an official intimation. The request pertains to Gagan Bharari Enterprises LLP, which currently holds no equity shares in Quick Heal Technologies.

Grounds for Reclassification

Gagan Bharari Enterprises LLP has cited specific reasons for seeking reclassification from Promoter Group to Public shareholder category. The entity has stated that it is not associated with the business or management of Quick Heal Technologies and does not engage in the company's management activities.

The applicant has confirmed that it does not have any rights to appoint directors or control management and policy decisions of the company. Additionally, the entity has provided comprehensive certifications regarding compliance with SEBI regulations for reclassification.

Regulatory Compliance and Certifications

As part of the reclassification application, Gagan Bharari Enterprises LLP has provided detailed certifications confirming compliance with regulatory requirements:

• Does not hold more than 10% of total voting rights
• Does not exercise control over company affairs
• Has no special rights through formal or informal arrangements
• Not represented on the Board of Directors
• Does not act as key managerial personnel
• Not classified as wilful defaulter or fugitive economic offender

Next Steps and Board Consideration

Quick Heal Technologies has indicated that the reclassification request will be considered in the upcoming Board meeting. The company has undertaken to follow necessary steps in compliance with Regulation 31A of the Listing Regulations.

The intimation to stock exchanges was made in compliance with Regulation 31A(8) of the Listing Regulations, with the copy of the request letter from Gagan Bharari Enterprises LLP enclosed with the official communication. Vikram Dhanani, Compliance Officer of Quick Heal Technologies, signed the intimation letter on January 22, 2026.